Noteworthy

Apr 13, 2017
Pharmaceutical Executive
Pharm Exec profiles Bahija Jallal, this year's Healthcare Businesswomen’s Association Woman of the Year.
Apr 06, 2017
Pharmaceutical Executive
Six years in, Pharm Exec looks at the progress of the International Rare Diseases Research Consortium.
Apr 06, 2017
Pharmaceutical Executive
Cheryl Key rounds up the expert debate the practice’s rise up the life sciences agenda.
Apr 06, 2017
Pharmaceutical Executive
Julian Upton reviews of some of the sales strategy insights on offer at last month’s eyeforpharma Barcelona event.
Apr 05, 2017
Scott Gottlieb answers Senators' questions at his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee.
Apr 04, 2017
Even though uncertainty still exists with Trump’s presidency, current laws will remain intact for the time being. That’s why having a strong compliance strategy in place is the safest bet for all life sciences companies. This article reviews the top of compliance for pharma to be on the look out for.
Apr 03, 2017
Greater patient involvement in regulatory processes is raising questions about whether the views expressed by such groups fully reflect broader public needs and values.
Apr 01, 2017
Pharmaceutical Executive
A conversation with Tommy Fanning, head of biopharma at IDA Ireland, about the country’s growth as a manufacturing powerhouse—and its bid to attract UK-based EMA post-Brexit.
Mar 24, 2017
Pharmaceutical Executive
Despite the investment in place, industry still struggles to take advantage of competitive intelligence as key decision aid.
Mar 22, 2017
FDA efforts to speed more new generic drugs to market probably won’t do much to reduce high drug prices, writes Jill Wechsler.
native1_300x100
lorem ipsum